Angela Koutsokera

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


90 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
2024
 
Prophylaxie de l’infection à Pneumocystis jirovecii chez les patients non VIH [Pneumocystis jirovecii infection prophylaxis in non-HIV infected individuals: Risk assessment and modalitiesw]
Sood R., Marando M., Gijs P.J., Balmpouzis Z., Bergeron A., Koutsokera A., Berra G., 2024/11/13. Revue medicale suisse, 20 (895) pp. 2110-2115. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0DA75A1E55AD]
 
Allergic bronchopulmonary aspergillosis as an initial manifestation of cystic fibrosis: Diagnostic and therapeutic implications in the era of CFTR modulators.
Mitropoulou G., Balmpouzis Z., Oberhansli-Wavre A., Morris M., Blanchon S., Sauty A., Koutsokera A., 2024/11. The journal of allergy and clinical immunology. Global, 3 (4) p. 100294. Peer-reviewed.
[DOI][Pmid][serval:BIB_ED7DA598F2E6]
 
One-Step Soft Agar Enrichment and Isolation of Human Lung Bacteria Inhibiting the Germination of Aspergillus fumigatus Conidia.
Palmieri F., Diserens J., Gresse M., Magnin M., Helle J., Salamin B., Bisanti L., Bernasconi E., Pernot J., Shanmuganathan A. et al., 2024/10/07. Microorganisms, 12 (10). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A68D1F08839D]
 
Allergic bronchopulmonary aspergillosis in a lung transplant recipient treated with mepolizumab.
Ioakeim F., Abellan C., Casutt A., Lechartier B., Noirez L., Beigelman-Aubry C., Aubert J.D., Balmpouzis Z., Koutsokera A., 2024/07. Clinical immunology, 264 p. 110265. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9992C8786F5C]
 
Antifungal drug penetration in soft tissue abscesses: a comparative analysis.
Cancela Costa A., Kritikos A., Glampedakis E., Da Silva Pereira Clara J., Schaller F., Mercier T., Strasser R., Balmpouzis Z., Koutsokera A., Manuel O. et al., 2024/07/01. The Journal of antimicrobial chemotherapy, 79 (7) pp. 1668-1672. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_94BC817AB3D7]
2023
Impact of COVID-19 on long-term lung function in lung transplant recipients: A single-center retrospective cohort study.
Touilloux B., Papadimitriou-Olivgeris M., Bongard C., Mansouri N., Ioakeim F., Manuel O., Koutsokera A., Aubert J.D., Casutt A., 2023/10. Transplant infectious disease, 25 (5) pp. e14151. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5A6B4651FB2C]
 
Fighting aspergillosis using biocontrol bacteria
Trompette Aurélien, Shanmuganathan Apiha, Pernot Julie, Palmieri Fabio, Bernasconi Eric, Von Garnier Christophe, Stucki Janick, Hobi Nina, Junier Pilar, Koutsokera Angela et al., 2023/09/09., ERS International Congress 2023 pp. PA2186 dans Respiratory infections and bronchiectasis.
[DOI][WoS][serval:BIB_386C28C0AC10]
 
The impact of COVID-19 on long term lung function in lung transplant recipients: a single-center retrospective study
Touilloux Brice, Papadimitriou-Olivgeris Matthaios, Bongard Cédric, Mansouri Nahal, Ioakeim Foteini, Aubert John-David, Manuel Oriol, Koutsokera Angela, Casutt Alessio, 2023/09/09., ERS International Congress 2023 pp. PA3365 dans Transplantation.
[DOI][WoS][serval:BIB_57DCCABB924B]
 
Interest of therapeutic drug monitoring: lumacaftor, ivacaftor, tezacaftor, and elexacaftor.
Choong Eva, Sauty A., Koutsokera A., Blanchon S., André Pascal, Decosterd L., 2023/03. dans Journée mucoviscidose romande March 2023 - Lausanne. Peer-reviewed.
[serval:BIB_27E71891505C]
Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts.
Pison C., Tissot A., Bernasconi E., Royer P.J., Roux A., Koutsokera A., Coiffard B., Renaud-Picard B., Le Pavec J., Mordant P. et al., 2023/03. Frontiers in medicine, 10 p. 1126697. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2182C7C738B4]
Lung Transplantation for Primary Ciliary Dyskinesia and Kartagener Syndrome: A Multicenter Study.
Marro M., Leiva-Juárez M.M., D'Ovidio F., Chan J., Van Raemdonck D., Ceulemans L.J., Moreno P., Kindelan A.A., Krueger T., Koutsokera A. et al., 2023/02. Transplant international, 36 p. 10819. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C2C71D48EDBF]
 
Outcomes of SARS-CoV-2 infection among lung transplant recipients: A single center retrospective study.
Casutt A., Papadimitriou-Olivgeris M., Ioakeim F., Aubert J.D., Manuel O., Koutsokera A., 2023/02. Transplant infectious disease, 25 (1) pp. e14007. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B46C384138BD]
2022
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations.
Mitropoulou G., Koutsokera A., Csajka C., Blanchon S., Sauty A., Brunet J.F., von Garnier C., Resch G., Guery B., 2022/12/31. European respiratory review, 31 (166) p. 220121. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E890AE6D6C1D]
 
Rectal organoid-guided CFTR modulator therapy restores lung function in a cystic fibrosis patient with the rare 1677delTA/R334W genotype.
Mitropoulou G., Brandenberg N., Hoehnel S., Ceroni C., Balmpouzis Z., Blanchon S., Dorta G., Sauty A., Koutsokera A., 2022/12. The European respiratory journal, 60 (6) p. 2201341. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DA1096E6DF8A]
Phagothérapie pour traiter les infections respiratoires [Phage therapy for respiratory infections]
Mitropoulou G., Gijs P.J., Koutsokera A., Sauty A., Blanchon S., Csajka C., Brunet J.F., Resch G., Guery B., Von Garnier C., 2022/11/16. Revue medicale suisse, 18 (804) pp. 2150-2156. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CCFF1CBAD0AE]
Quand penser à la transplantation pulmonaire ? [When to consider lung transplantation?]
Ioakeim F., Mazza T., Casutt A., Balmpouzis Z., Lechartier B., Krueger T., Aubert J.D., Berra G., Koutsokera A., 2022/11/16. Revue medicale suisse, 18 (804) pp. 2143-2149. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D30BECB3669C]
 
Effects of elexacaftor-tezacaftor-ivacaftor discontinuation in cystic fibrosis.
Mitropoulou G., Balmpouzis Z., Plojoux J., Dotta-Celio J., Sauty A., Koutsokera A., 2022/11. Respiratory medicine and research, 82 p. 100972. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_741FDE1E5F76]
Frailty predicts outcomes in cystic fibrosis patients listed for lung transplantation.
Koutsokera A., Sykes J., Theou O., Rockwood K., Steinack C., Derkenne M.F., Benden C., Krueger T., Chaparro C., Aubert J.D. et al., 2022/11. The Journal of heart and lung transplantation, 41 (11) pp. 1617-1627. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CE08DB438AE5]
Syndrome des télomères courts chez l’adulte : une entité rare qu’il faut savoir évoquer [Short telomere syndrome in adults: a rare entity that should be evoked]
Coukos A., Daccord C., Lazor R., Blum S., Naveiras O., Unger S., Vionnet J., Gaide O., Koutsokera A., Moschouri E. et al., 2022/08/31. Revue medicale suisse, 18 (793) pp. 1606-1613. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_610156412D48]
Therapeutic Drug Monitoring of Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis: Where Are We Now?
Choong E., Sauty A., Koutsokera A., Blanchon S., André P., Decosterd L., 2022/08/11. Pharmaceutics, 14 (8) p. 1674. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0CAC2AC96B31]
 
Extracorporeal life support as a bridge to pulmonary retransplantation: prognostic factors for survival in a multicentre cohort analysis.
Inci I., Ehrsam J.P., Van Raemdonck D., Ceulemans L.J., Krüger T., Koutsokera A., Schiavon M., Faccioli E., Nosotti M., Rosso L. et al., 2022/01/24. European journal of cardio-thoracic surgery, 61 (2) pp. 405-412. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1CECF7BB4999]
Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies With a Focus on Aspergillus spp.
Palmieri F., Koutsokera A., Bernasconi E., Junier P., von Garnier C., Ubags N., 2022. Frontiers in medicine, 9 p. 832510. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DB72BBC66F14]
Successful pregnancy in a cystic fibrosis patient with a severe impairment of lung function receiving Elexacaftor-Tezacaftor-Ivacaftor.
Balmpouzis Z., Faure van Rossum A., Baud D., Panchaud A., Mitropoulou G., Mazza Stalder J., Koutsokera A., 2022. Respiratory medicine case reports, 40 p. 101776. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_40C6261EB44B]
2021
 
Acute Rejection in the Modern Lung Transplant Era.
Renaud-Picard B., Koutsokera A., Cabanero M., Martinu T., 2021/06. Seminars in respiratory and critical care medicine, 42 (3) pp. 411-427. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F8FB00FB37A2]
 
Endobronchial coil spring fiducial markers for CyberKnife® stereotactic body radiation therapy.
Casutt A., Noirez L., Bernasconi M., Koutsokera A., Beigelman-Aubry C., Kinj R., Ozsahin E.M., Durham A.D., von Garnier C., Lovis A., 2021/05. Respirology, 26 (5) pp. 469-476. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C98C6D8E75E9]
 
A prevalent and culturable microbiota links ecological balance to clinical stability of the human lung after transplantation.
Das S., Bernasconi E., Koutsokera A., Wurlod D.A., Tripathi V., Bonilla-Rosso G., Aubert J.D., Derkenne M.F., Mercier L., Pattaroni C. et al., 2021/04/09. Nature communications, 12 (1) p. 2126. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_231E626287AA]
 
Bronchial anastomosis dehiscence and stenosis caused by donor-transmitted Mycoplasma hominis infection in a lung transplant recipient: Case report and literature review.
Vecchio M., Koutsokera A., Touilloux B., Perentes J.Y., Manuel O., Noirez L., Aubert J.D., Lenoir A., 2021/04. Transplant infectious disease, 23 (2) pp. e13475. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_418461DBDCC0]
 
Understanding rare infections post-lung transplantation.
van den Bogaart L., Cipriano A., Koutsokera A., Manuel O., 2021/03. Expert review of respiratory medicine, 15 (3) pp. 325-338. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C445B7ADA73E]
2020
International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation.
Martinu T., Koutsokera A., Benden C., Cantu E., Chambers D., Cypel M., Edelman J., Emtiazjoo A., Fisher A.J., Greenland J.R. et al., 2020/11. The Journal of heart and lung transplantation, 39 (11) pp. 1171-1190. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_841CA273F199]
 
Rare indications for a lung transplant. A European Society of Thoracic Surgeons survey.
Nosotti M., D'Ovidio F., Leiva-Juarez M., Keshavjee S., Rackauskas M., Van Raemdonck D., Ceulemans L.J., Krueger T., Koutsokera A., Schiavon M. et al., 2020/11/01. Interactive cardiovascular and thoracic surgery, 31 (5) pp. 638-643. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B6C5F24A5627]
Révolution dans le traitement de la mucoviscidose [Revolution in the treatment of cystic fibrosis]
Sauty A., Plojoux J., Mornand A., Blanchon S., Koutsokera A., 2020/06/17. Revue medicale suisse, 16 (698) pp. 1229-1235. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EC0F290D1773]
Perceptions towards physical activity in adult lung transplant recipients with cystic fibrosis
Wietlisbach Martina, Benden Christian, Koutsokera Angela, Jahn Kathleen, Soccal Paola M., Radtke Thomas, 2020/02/21. PLOS ONE, 15 (2) pp. e0229296. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7ACA7C0CB2B8]
 
Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis.
Koutsokera A., Corriveau S., Sykes J., Coriati A., Cortes D., Vadas P., Chaparro C., McIntyre K., Tullis E., Stephenson A.L., 2020/01. Journal of cystic fibrosis, 19 (1) pp. 119-124. Peer-reviewed.
[DOI][Pmid][serval:BIB_80E31BF3C8BC]
2019
 
Blood CD9<sup>+</sup> B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation.
Brosseau C., Danger R., Durand M., Durand E., Foureau A., Lacoste P., Tissot A., Roux A., Reynaud-Gaubert M., Kessler R. et al., 2019/11. American journal of transplantation, 19 (11) pp. 3162-3175. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3938D0483818]
 
Rethinking bronchoalveolar lavage in acute cellular rejection: How golden is the standard of transbronchial biopsies?
Koutsokera A., 2019/08. The Journal of heart and lung transplantation, 38 (8) pp. 856-857. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_75BB1BB36F13]
 
Pre-transplant factors associated with mortality after lung transplantation in cystic fibrosis: A systematic review and meta-analysis.
Koutsokera A., Varughese R.A., Sykes J., Orchanian-Cheff A., Shah P.S., Chaparro C., Tullis E., Singer L.G., Stephenson A.L., 2019/05. Journal of cystic fibrosis, 18 (3) pp. 407-415. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_39C08E71404C]
Swiss Recommendations for Adult Cystic Fibrosis Care: Transplantation
Benden Christian, McLin Valérie, Bürgi Urs, Huber Lars C., Koutsokera Angela, Aubert John-David, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_17550E3D7A23]
Swiss Recommendations for Adult Cystic Fibrosis Care: Allergic bronchopulmonary aspergillosis (ABPA)
Fellrath Jean-Marc, Koutsokera Angela, Challet Corinne, Sauty Alain, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_5E78FF372A31]
Swiss Recommendations for Adult Cystic Fibrosis Care: Annual assessment
Koutsokera Angela, Benden Christian, Fischer Reta, Kleiner Rebekka, Fellrath Jean-Marc, Geiser Thomas, Hofer Markus, Irani Sarosh, Rochat Thierry, Sauty Alain, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_37738F0D3940]
Swiss Recommendations for Adult Cystic Fibrosis Care: Bone disease
Koutsokera Angela, Lamy Olivier, Challet Corinne, Hofer Markus, Schmid Christoph, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_BD109A14D95A]
Swiss Recommendations for Adult Cystic Fibrosis Care: Burkholderia cepacia complex
Sauty Alain, Manuel Oriol, Koutsokera Angela, Tullis Elizabeth, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_930B3358F5E7]
Swiss Recommendations for Adult Cystic Fibrosis Care: CF-related diabetes
Koutsokera Angela, Troendle Amineh , Moran Antoinette , 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_3C99A12C43DF]
Swiss Recommendations for Adult Cystic Fibrosis Care: Diagnosis in adults
Koutsokera Angela, Sauty Alain, Morris Michael A., Tullis Elizabeth, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_9F5062AF130F]
Swiss Recommendations for Adult Cystic Fibrosis Care: Fungi
Mueller Nicolas J, Koutsokera Angela, Waters Valerie, van Delden Christian, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_D2D97B43B166]
Swiss Recommendations for Adult Cystic Fibrosis Care: Nutrition
Stamm Elisabeth, Yersin Estelle, Chabal Laurent, Coti Bertrand Pauline , Challet Corinne, Petit Laetitia-Marie , Koutsokera Angela, Sauty Alain, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_E093D27F9674]
Swiss Recommendations for Adult Cystic Fibrosis Care: Other relevant bacteria (Bordetella species)
Koutsokera Angela, Manuel Oriol, Sauty Alain, Müller Nicolas, Benden Christian, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_A4107A569CBF]
Swiss Recommendations for Adult Cystic Fibrosis Care: Oxygen therapy and non-invasive ventilation (NIV)
Prella Maura, Koutsokera Angela, Irani Sarosh, Dumans Cédric, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_A156CA1E2C89]
Swiss Recommendations for Adult Cystic Fibrosis Care: Pathogenesis of CF
Koutsokera Angela, Tullis Elizabeth, Chanson Marc, Sauty Alain, Morris Michael A., 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_D5FEA9123A02]
Swiss Recommendations for Adult Cystic Fibrosis Care: Renal diseases
Koutsokera Angela, Bullani Roberto, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_FEA4BEE130B3]
Swiss Recommendations for Adult Cystic Fibrosis Care: Staphylococcus aureus
Sauty Alain, Manuel Oriol, Koutsokera Angela, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_766A09033B27]
Swiss Recommendations for Adult Cystic Fibrosis Care: Urinary diseases
Koutsokera Angela, Bullani Roberto, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_DD25FF4280E4]
Swiss Recommendations for Adult Cystic Fibrosis Care: Vaccination
Manuel Oriol, Koutsokera Angela, Sauty Alain, 2019/05/01. dans Swiss Recommendations for Adult Cystic Fibrosis Care, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_AE9C6040100D]
 
Compromised immunity and the microbiome: transplantation, cancer and HIV
Bernasconi Eric, Aubert John-David, Koutsokera Angela, Nicod Laurent P., Twigg III Homer L., 2019/03. pp. 195-215 dans The Lung Microbiome chap. 12, European Respiratory Society.
[DOI][serval:BIB_3D43CABD1476]
2018
 
COLT : 10 ans de recherche en transplantation pulmonaire, résultats et perspectives [COLT: Ten years of research in lung transplantation, results and perspectives]
Tissot A., Foureau A., Brosseau C., Danger R., Roux A., Bernasconi E., Gomez C., Durand M., Picard B.R., Le Pavec J. et al., 2018/09. Revue des maladies respiratoires, 35 (7) pp. 699-705. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2614FC766414]
 
Clinical significance of post-prophylaxis cytomegalovirus infection in lung transplant recipients.
Jaamei N., Koutsokera A., Pasquier J., Mombelli M., Meylan P., Pascual M., Aubert J.D., Manuel O., 2018/08. Transplant infectious disease, 20 (4) pp. e12893. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_53680F51E25F]
 
Acute Cellular Rejection: Is It Still Relevant?
Koutsokera A., Levy L., Pal P., Orchanian-Cheff A., Martinu T., 2018/04. Seminars in respiratory and critical care medicine, 39 (2) pp. 181-198. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_03C8F5B02473]
Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung.
Mouraux S., Bernasconi E., Pattaroni C., Koutsokera A., Aubert J.D., Claustre J., Pison C., Royer P.J., Magnan A., Kessler R. et al., 2018/02. The Journal of allergy and clinical immunology, 141 (2) pp. 718-729.e7. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8E8414112FB7]
Distinct Genomic Features Characterize Two Clades of <i>Corynebacterium diphtheriae</i>: Proposal of <i>Corynebacterium diphtheriae</i> Subsp. <i>diphtheriae</i> Subsp. nov. and <i>Corynebacterium diphtheriae</i> Subsp. <i>lausannense</i> Subsp. nov.
Tagini F., Pillonel T., Croxatto A., Bertelli C., Koutsokera A., Lovis A., Greub G., 2018. Frontiers in microbiology, 9 p. 1743. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0A00CF043EE5]
Swiss Recommendations for Adult Cystic Fibrosis Care: Psychological Issues
Hersch Déborah, Saraga Michael, Koutsokera Angela, 2018. dans Swiss Recommendations for Adult Cystic Fibrosis Care chap. 14, RMS Editions/Médecine et Hygiène.
[URN][serval:BIB_9CC689C5CAC7]
2017
Iatrogenic bleeding during flexible bronchoscopy: risk factors, prophylactic measures and management.
Bernasconi M., Koegelenberg CFN, Koutsokera A., Ogna A., Casutt A., Nicod L., Lovis A., 2017/04. ERJ open research, 3 (2) pp. e1. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_BCB120555280]
 
Linear-Endobronchial Ultrasound-Guided Insertion of a Fiducial Marker: A New Tool for Tracking Central Lesions.
Casutt A., Koutsokera A., Peguret N., Lovis A., 2017/04. Journal of bronchology & interventional pulmonology, 24 (2) pp. 166-169. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_877DEFE7A875]
Blood Gene Expression Predicts Bronchiolitis Obliterans Syndrome.
Danger R., Royer P.J., Reboulleau D., Durand E., Loy J., Tissot A., Lacoste P., Roux A., Reynaud-Gaubert M., Gomez C. et al., 2017. Frontiers in immunology, 8 p. 1841. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CE8A4B3B6EA6]
Development of a Multivariate Prediction Model for Early-Onset Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome in Lung Transplantation.
Koutsokera A., Royer P.J., Antonietti J.P., Fritz A., Benden C., Aubert J.D., Tissot A., Botturi K., Roux A., Reynaud-Gaubert M.L. et al., 2017. Frontiers in medicine, 4 p. 109. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CD968A83EB29]
2016
 
Radial Ultrasound-Assisted Transbronchial Biopsy: A New Diagnostic Approach for Non-Resolving Pulmonary Infiltrates in Neutropenic Hemato-Oncological Patients.
Bernasconi M., Casutt A., Koutsokera A., Letovanec I., Tissot F., Nicod L.P., Lovis A., 2016/12. Lung, 194 (6) pp. 917-921. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5FC2874DDD0E]
 
Airway Microbiota Determines Innate Cell Inflammatory or Tissue Remodeling Profiles in Lung Transplantation.
Bernasconi E., Pattaroni C., Koutsokera A., Pison C., Kessler R., Benden C., Soccal P.M., Magnan A., Aubert J.D., Marsland B.J. et al., 2016/11/15. American journal of respiratory and critical care medicine, 194 (10) pp. 1252-1263. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_15B0E7AC9773]
 
Chronic Lung Allograft Dysfunction : A Systematic Review of Mechanisms
Royer Pierre-Joseph, Olivera-Botello Gustavo, Koutsokera Angela, Aubert John-David, Bernasconi Eric, Tissot Adrien, Pison Christophe, Nicod Laurent, Boissel Jean-Pierre, Magnan Antoine, 2016/09. Transplantation, 100 (9) pp. 1803-1814.
[URN][DOI][WoS][Pmid][serval:BIB_C9EEC769C3E5]
 
Late Major Hemoptysis After Lung Volume Reduction With Coils Induced by Dual Antiaggregation Therapy.
Valenti A., Casutt A., Koutsokera A., Noetzli J., Perentes J.Y., Krueger T., Pons M., Nicod L.P., Lovis A., 2016. Annals of Thoracic Surgery, 101 (2) pp. e49-e50. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2452E64E07ED]
 
Lung Volume Reduction Coil Treatment: Is There an Indication for Antibiotic Prophylaxis?
Casutt A., Koutsokera A., Lovis A., 2016. Archivos De Bronconeumología, 52 (2) pp. 114-115. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_686E7183C7A9]
 
Safety of drugs during pregnancy and breastfeeding in cystic fibrosis patients.
Panchaud A., Di Paolo E.R., Koutsokera A., Winterfeld U., Weisskopf E., Baud D., Sauty A., Csajka C., 2016. Respiration; international review of thoracic diseases, 91 (4) pp. 333-348. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C8F67FDB86FD]
2015
 
Fluoroscopic-Guided Radial Endobronchial Ultrasound Without Guide Sheath For Peripheral Pulmonary Lesions: A Safe And Efficient Combination.
Casutt A., Prella M., Beigelman-Aubry C., Fitting J.W., Nicod L., Koutsokera A., Lovis A., 2015/07. Archivos de bronconeumologia, 51 (7) pp. 338-343. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_046D78F7CDBC]
 
A 3-step therapeutic strategy for severe alveolar proteinosis.
Noirez L., Koutsokera A., Pantet O., Duss F.R., Eggimann P., Tozzi P., Gonzalez M., Coronado M., Nicod L.P., Lovis A., 2015. Annals of Thoracic Surgery, 99 (4) pp. 1456-1458. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_032C94B12F21]
2014
 
Complications of Valve Lung Volume Reduction in a Case of Previous Pleurodesis.
Koutsokera A., Noirez L., Gonzalez M., Beigelman-Aubry C., Ris H.B., Aubert J.D., Lovis A., 2014. Annals of Thoracic Surgery, 98 (3) pp. e71-e72. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A659CDC64F52]
 
Prediction of chronic lung allograft dysfunction: a systems medicine challenge.
Pison C., Magnan A., Botturi K., Sève M., Brouard S., Marsland B.J., Ernst F., Paprotka T., Deplanche K., Fritz A. et al., 2014. European Respiratory Journal, 43 (3) pp. 689-693.
[DOI][WoS][Pmid][serval:BIB_9E261179C87C]
2013
 
Polymorphisms and haplotypes in MyD88 are associated with the development of sarcoidosis: a candidate-gene association study.
Daniil Z., Mollaki V., Malli F., Koutsokera A., Antoniou K.M., Rodopoulou P., Gourgoulianis K., Zintzaras E., Vassilopoulos G., 2013/07. Molecular biology reports, 40 (7) pp. 4281-4286. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_083CA6D82427]
Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept.
Malli F., Koutsokera A., Paraskeva E., Zakynthinos E., Papagianni M., Makris D., Tsilioni I., Molyvdas P.A., Gourgoulianis K.I., Daniil Z., 2013. PloS one, 8 (1) pp. e53658. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_364DCD37BB1C]
Pulmonary biomarkers in COPD exacerbations: a systematic review.
Koutsokera A., Kostikas K., Nicod L.P., Fitting J.W., 2013. Respiratory Research, 14 (1) p. 111. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_409651195727]
2012
 
Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge.
Koutsokera A., Stolz D., Loukides S., Kostikas K., 2012/02. Chest, 141 (2) pp. 396-405. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_84F88910EE32]
2011
 
Exhaled NO and exhaled breath condensate pH in the evaluation of asthma control.
Kostikas K., Papaioannou A.I., Tanou K., Giouleka P., Koutsokera A., Minas M., Papiris S., Gourgoulianis K.I., Taylor D.R., Loukides S., 2011/04. Respiratory medicine, 105 (4) pp. 526-532. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BA927963B11F]
 
Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease.
Markoulaki D., Kostikas K., Papatheodorou G., Koutsokera A., Alchanatis M., Bakakos P., Gourgoulianis K.I., Roussos C., Koulouris N.G., Loukides S., 2011/02. European journal of internal medicine, 22 (1) pp. 103-107. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CA578268D853]
 
Noninvasive ventilation in chronic respiratory failure: effects on quality of life.
Tsolaki V., Pastaka C., Kostikas K., Karetsi E., Dimoulis A., Zikiri A., Koutsokera A., Gourgoulianis K.I., 2011. Respiration; international review of thoracic diseases, 81 (5) pp. 402-410. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3A4AC7F50D32]
2010
 
Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
Krommidas G., Kostikas K., Papatheodorou G., Koutsokera A., Gourgoulianis K.I., Roussos C., Koulouris N.G., Loukides S., 2010/01. Respiratory medicine, 104 (1) pp. 40-46. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B0F7666C6C66]
2009
 
Systemic oxidative stress in patients with pulmonary sarcoidosis.
Koutsokera A., Papaioannou A.I., Malli F., Kiropoulos T.S., Katsabeki A., Kerenidi T., Gourgoulianis K.I., Daniil Z.D., 2009/12. Pulmonary pharmacology & therapeutics, 22 (6) pp. 603-607. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A8CD15EAA7F5]
 
Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate-gene association study.
Mollaki V., Georgiadis T., Tassidou A., Ioannou M., Daniil Z., Koutsokera A., Papathanassiou A.A., Zintzaras E., Vassilopoulos G., 2009/11. Journal of human genetics, 54 (11) pp. 655-659. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D5DD8D66EA43]
 
Clinical, functional and biochemical changes during recovery from COPD exacerbations.
Koutsokera A., Kiropoulos T.S., Nikoulis D.J., Daniil Z.D., Tsolaki V., Tanou K., Papaioannou A.I., Germenis A., Gourgoulianis K.I., Kostikas K., 2009/06. Respiratory medicine, 103 (6) pp. 919-926. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_52A451D3C958]
 
Inflammatory and oxidative stress biomarkers in allergic rhinitis: the effect of smoking.
Tanou K., Koutsokera A., Kiropoulos T.S., Maniati M., Papaioannou A.I., Georga K., Zarogiannis S., Gourgoulianis K.I., Kostikas K., 2009/03. Clinical and experimental allergy, 39 (3) pp. 345-353. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ACF134939A13]
2008
 
One-year non-invasive ventilation in chronic hypercapnic COPD: effect on quality of life.
Tsolaki V., Pastaka C., Karetsi E., Zygoulis P., Koutsokera A., Gourgoulianis K.I., Kostikas K., 2008/06. Respiratory medicine, 102 (6) pp. 904-911. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_28AFD5E86944]
 
Exhaled breath condensate in patients with asthma: implications for application in clinical practice.
Kostikas K., Koutsokera A., Papiris S., Gourgoulianis K.I., Loukides S., 2008/04. Clinical and experimental allergy, 38 (4) pp. 557-565. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8E5D82365942]
 
Portable exhaled nitric oxide as a screening tool for asthma in young adults during pollen season.
Kostikas K., Papaioannou A.I., Tanou K., Koutsokera A., Papala M., Gourgoulianis K.I., 2008/04. Chest, 133 (4) pp. 906-913. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_857AF19AAE86]
2007
 
Discrimination of exudative pleural effusions based on multiple biological parameters.
Daniil Z.D., Zintzaras E., Kiropoulos T., Papaioannou A.I., Koutsokera A., Kastanis A., Gourgoulianis K.I., 2007/11. The European respiratory journal, 30 (5) pp. 957-964. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7D7BF320F5A1]
2006
 
Combined pulmonary fibrosis and emphysema in patients exposed to agrochemical compounds.
Daniil Z., Koutsokera A., Gourgoulianis K., 2006/02. The European respiratory journal, 27 (2) p. 434. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7BD6C26DCF76]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University